Together with terbinafine and fluconazole, itraconazole belongs to the modern

highly effective systemic antifungal drugs DZNeP clinical trial with a favorable risk-benefit ratio and for this reason is a preferred therapy option for fungal infections of skin, nails and mucous membranes. Compared to terbinafine in the treatment of fingernail and toenail fungal infections, itraconazole offers the advantage of a broad antifungal spectrum and better effectiveness against onychomycosis caused by yeasts yet appears inferior with regard to the more common dermatophyte infections. Itraconazole constitutes an important therapy option, along with fluconazole, terbinafine, ketoconazole and griseofulvin, for the treatment of dermatophyte infections of glabrous skin (tinea pedis, tinea manuum, tinea corporis and tinea cruris) in adults following unsuccessful topical therapy. In the oral therapy of tinea capitis, itraconazole plays an especially important role, in particular for disease caused by Microsporum canis (for children, however, only off-label use is feasible currently). In the treatment of oropharyngeal candidiasis, candidiasis of the skin and vulvovaginal candidiasis, itraconazole and fluconazole are the

preferred treatment options in cases in which topical therapy has proven unsuccessful.”
“African PD98059 trypanosomiases, including the human disease referred to as ‘sleeping sickness’ and Dinaciclib ic50 the animal diseases such as nagana, surra and dourine, are neglected vector-borne diseases that after years of research still need improved diagnosis and chemotherapy. Advances in proteomics offer new tools to define biomarkers, whose expression may reflect host-parasite interactions

occurring during the infection. In this review, the authors first describe the current diagnostic tools used to detect a trypanosome infection during field surveys, and then discuss their interests, limits and further evolutions. The authors also report on the contribution of molecular diagnostics, and the recent advances and developments that make it suitable for fieldwork. The authors then explore the recent uses of proteomics technology to define host and parasite biomarkers that allow detection of the infection, the power and constraints of the technology. The authors conclude by discussing the urgent need to use the biomarkers discovered in order to develop tools to improve trypanosomiasis control in the near future.”
“Baccharis is an important genus of Asteraceae and it comprehends approximately 400 species, many of which are frequently used in folk medicine as analgesic, diuretic, spasmolytic, antidiabetic, antiseptic and stomachic. Baccharis singularis belongs to the Singularis group and is popularly known as cambara-de-praia and cambara-da-serra. It is a shrub which occurs in Brazil, from Bahia to Rio Grande do Sul.